oral glp-1 agonist brand name Novo Nordisk's drug didn't work on Alzheimer's as hoped, but don't call it a failure Decoding GLP-1 Weight Loss Medications
Description
Nearly 30 percent of people lost 20 percent or more of their weight
This article examines the scientific evidence, potential mechanisms, clinical applications, and important safety considerations surrounding low-dose GLP-1 therapy for inflammatory conditions
Regul Toxicol Pharmacol
Endocrine (2021) 73(2):32530
What about combining GLP-1s and surgery? Some patients do benefit from adjunctive use of GLP-1 therapy after surgery, especially when weight loss plateaus or to manage regain
b represents reports with target drug exposure but without target AEs
